Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFE-CRP: Telmisartan in Cardiovascular Risk Patients
NCT00274105Phase 4Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2001
- Primary completion
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of telmisartan in coronary artery disease (CAD), atherosclerosis, sponsored by Boehringer Ingelheim. Started Mar 2001; status: terminated.
02
Drugs
telmisartan
03
Conditions
coronary artery disease (CAD)atherosclerosis
Beyond the preview
Go deeper on NCT00274105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274105.